4
Changes in Ownership
Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-25-011303
Executive Vice President & CFO sold 100,000 shares at $8.91 ($891,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Konidaris Tasos Executive Vice President & CFO | 2025-03-05 | Sale | −100,000 | $8.91 | $891,000 | 621,882 | D |
| Open-market sales · 100,000 sh · avg $8.91 · $891,000 | |||||||
Loading xslF345X05/wk-form4_1741382230.xml…